Vor Biopharma's GAAP loss for 6M 2021 was $32.093 million, doubling from $15.889 million in the previous year.
Vor Biopharma's GAAP loss for 6M 2021 was $32.093 million, doubling from $15.889 million in the previous year.
Financial results
Vor Biopharma's GAAP loss for 6M 2021 was $32.093 million, doubling from $15.889 million in the previous year. Source: 
ir.vorbio.com
ir.vorbio.com
English (US) 